Company Profiles

driven by the PitchBook Platform

PharmaNeuroBoost

Description

Developer of central nervous system therapeutics. The develops two anti-depression drugs PNB01 and PNB02, which are combination medicines that strive to reinforce the effect of SSRIs, an important class of anti-depressants (PNB01) and of atypical antipsychotics (PNB02).

2006

Founded

PRIVATE

Status

PE Growth

Latest Deal Type

$30.7M

Total Amount Raised

4

Investors

Description

Developer of central nervous system therapeutics. The develops two anti-depression drugs PNB01 and PNB02, which are combination medicines that strive to reinforce the effect of SSRIs, an important class of anti-depressants (PNB01) and of atypical antipsychotics (PNB02).

Website:

www.pharmaneuroboost.com

Ownership Status

Privately held (backing)

Financing Status

Private Equity-Backed

Primary Industry

Pharmaceuticals

Primary Office

Alkerstraat 30 A 3570 AlkenBelgium +32 (0)1 148 07 50
Request a free trial to the PitchBook Platform
You're viewing a free company profile from the PitchBook Platform. To explore PharmaNeuroBoost's full profile, request a free trial.

PharmaNeuroBoost Valuation and Funding

Request access
Deal TypeDateAmountRaised to DatePost-ValStatusStage

PharmaNeuroBoost Investors (4)

Request access
Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
Seat
Contact
Info
Biovest (Belgium)Venture CapitalMinority000 0000000 0000
KBC ArkivPE/BuyoutMinority000 0000000 0000
KBC Private EquityPE/BuyoutMinority000 0000000 0000
Saffelberg InvestmentsGrowth/ExpansionMinority000 0000000 0000
Biovest (Belgium) Venture Capital
KBC Arkiv PE/Buyout
KBC Private Equity PE/Buyout
Saffelberg Investments Growth/Expansion

PharmaNeuroBoost Executive Team (5)

NameTitleBoard
Seat
Contact
Info
Remi Broeck MDPresident & Chief Development Officer
Didier Chaffoy Ph.DChief Scientific Officer
Philippe Lemmens Ph.DDirector, Clinical Development
Patricia Baede Ph.DDirector Regulatory Affairs
Els HublouxDirector
Remi Broeck MD President & Chief Development Officer
Didier Chaffoy Ph.D Chief Scientific Officer
Philippe Lemmens Ph.D Director, Clinical Development
Patricia Baede Ph.D Director Regulatory Affairs
Els Hubloux Director

PharmaNeuroBoost Board Members (2)

NameRepresentingRoleSinceContact
Info
Jo BreeshSelfBoard Member000 0000
Rudi MarienSelfBoard Member000 0000
Jo Breesh Board Member Self
Rudi Marien Board Member Self
Request full access to PitchBook